An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are encouraged to message these profiles privately for source information, while also receiving discount codes.
Active Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with numerous of members share comparison photos, administration instructions and claims of rapid British shipping. Vendors market the drug there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Worries
However, physicians and chemists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users administering substances of unknown origin.
Some experts said the popularity for retatrutide could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, legal action or imprisonment.
Platform Reaction and Material Removal
Based on TikTok, the platform has removed violative material and prohibited associated hashtags and search suggestions. The organization said it was dedicated to keeping the platform secure and allocating resources in strengthening compliance measures.
Online Trading Operations
Research also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, filled with photos of weight loss, glowing testimonials and detailed instructions for mixing or injecting at residence.
Within moments of entering one group, a seller shared contact information, where the majority of transactions occur. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about body mass, medical conditions or past usage.
Product Details and Pricing
Within these communities, posts display black plastic packages with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Service Moderation and Security Actions
A representative for Telegram said it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has already seen patients injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject patients to possibly serious health risks”.
